Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.
暂无分享,去创建一个
Nikos Evangelou | Christopher Tench | Peter Morris | Paul S Morgan | Tim Jaspan | P. Morgan | C. Tench | P. Morris | N. Evangelou | T. Jaspan | J. Dixon | E. Tallantyre | N. Mistry | Rasha Abdel-Fahim | Niraj Mistry | Jennifer Dixon | Emma Tallantyre | R. Abdel-Fahim
[1] P S Morgan,et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions , 2011, Neurology.
[2] Helen Tremlett,et al. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts , 2010, Journal of the Neurological Sciences.
[3] Ludwig Kappos,et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study , 2007, The Lancet.
[4] T. Ben-Hur,et al. Patterns of misdiagnosis of multiple sclerosis. , 2003, The Israel Medical Association journal : IMAJ.
[5] Seth Love,et al. Greenfield's neuropathology , 2015 .
[6] J. Stockman,et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study , 2009 .
[7] A. Rovira,et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? , 2008, Neurology.
[8] F. Barkhof,et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis , 1999, Neurology.
[9] Peter Gordon Morris,et al. Optimisation of T₂*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T. , 2013, European journal of radiology.
[10] Marco Rovaris,et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.
[11] T. Fog. ON THE VESSEL‐PLAQUE RELATIONSHIPS IN THE BRAIN IN MULTIPLE SCLEROSIS , 1964, Acta neurologica Scandinavica. Supplementum.
[12] D Miller,et al. The differential diagnosis of multiple sclerosis , 2006, McAlpine's Multiple Sclerosis.
[13] J H Simon,et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.
[14] P. Pretorius,et al. The role of MRI in the diagnosis of MS. , 2003, Clinical radiology.
[15] F Barkhof,et al. MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.
[16] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[17] J. Benito-León,et al. Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes , 2010, Multiple sclerosis.
[18] Jullie W Pan,et al. DEMONSTRATING THE PERIVASCULAR DISTRIBUTION OF MS LESIONS IN VIVO WITH 7-TESLA MRI , 2008, Neurology.